Pembrolizumab with chemotherapy then olaparib maintenance for treating BRCA-negative advanced epithelial ovarian, fallopian tube or peritoneal cancer [ID3853]

  • Discontinued
  • GID-TA10747

Documents

Documents created during the development process.

Notes